Large‐scale characterization study of patients with antimitochondrial antibodies but nonestablished primary biliary cholangitis

Géraldine Dahlqvist, Farid Gaouar, Fabrice Carrat, Sofia Meurisse, Olivier Chazouillères, Raoul Poupon, Catherine Johanet, Christophe Corpechot, the French network of Immunology Laboratories – 30 September 2016 – The prevalence, clinical characteristics, and outcomes of patients with antimitochondrial antibodies (AMAs), but no clinical evidence of primary biliary cholangitis (PBC), are largely unknown. A prospective study of AMA incidence was conducted through a nation‐wide network of 63 French immunology laboratories.

Subscribe to